Wall Street analysts expect Patterson Companies, Inc. (NASDAQ:PDCO) to post earnings per share (EPS) of $0.40 for the current fiscal quarter, Zacks reports. Seven analysts have issued estimates for Patterson Companies’ earnings. The lowest EPS estimate is $0.39 and the highest is $0.41. Patterson Companies reported earnings of $0.30 per share in the same quarter last year, which would indicate a positive year over year growth rate of 33.3%. The business is scheduled to announce its next quarterly earnings report before the market opens on Thursday, June 27th.
On average, analysts expect that Patterson Companies will report full year earnings of $1.43 per share for the current fiscal year, with EPS estimates ranging from $1.42 to $1.45. For the next financial year, analysts forecast that the business will post earnings of $1.53 per share, with EPS estimates ranging from $1.50 to $1.55. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Patterson Companies.
A number of analysts have weighed in on PDCO shares. Guggenheim started coverage on shares of Patterson Companies in a research note on Wednesday, April 17th. They set a “neutral” rating and a $23.00 target price on the stock. BidaskClub downgraded shares of Patterson Companies from a “strong-buy” rating to a “buy” rating in a research report on Thursday, March 7th. Wolfe Research initiated coverage on shares of Patterson Companies in a research report on Thursday, May 30th. They issued an “underperform” rating for the company. Zacks Investment Research downgraded shares of Patterson Companies from a “hold” rating to a “sell” rating in a research report on Wednesday, February 27th. Finally, ValuEngine raised shares of Patterson Companies from a “sell” rating to a “hold” rating in a research report on Friday, March 1st. Five equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. Patterson Companies currently has a consensus rating of “Hold” and a consensus target price of $21.50.
NASDAQ:PDCO traded up $0.02 during mid-day trading on Tuesday, reaching $22.10. The stock had a trading volume of 446,560 shares, compared to its average volume of 819,507. The stock has a market capitalization of $2.10 billion, a price-to-earnings ratio of 13.15, a price-to-earnings-growth ratio of 2.57 and a beta of 1.27. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.80 and a quick ratio of 0.89. Patterson Companies has a 12 month low of $18.94 and a 12 month high of $26.60.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Rowland & Co. Investment Counsel ADV increased its holdings in Patterson Companies by 4.3% in the 1st quarter. Rowland & Co. Investment Counsel ADV now owns 104,834 shares of the company’s stock worth $2,291,000 after buying an additional 4,294 shares during the period. Legal & General Group Plc grew its position in Patterson Companies by 1.7% in the 4th quarter. Legal & General Group Plc now owns 110,521 shares of the company’s stock valued at $2,173,000 after acquiring an additional 1,892 shares in the last quarter. Oppenheimer Asset Management Inc. grew its position in Patterson Companies by 19.0% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 28,790 shares of the company’s stock valued at $566,000 after acquiring an additional 4,593 shares in the last quarter. First Citizens Bank & Trust Co. acquired a new position in Patterson Companies in the 1st quarter valued at about $359,000. Finally, Quantamental Technologies LLC acquired a new position in Patterson Companies in the 4th quarter valued at about $126,000. Hedge funds and other institutional investors own 93.65% of the company’s stock.
About Patterson Companies
Patterson Companies, Inc distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through Dental and Animal Health segments. The company's Dental segment offers consumable products, such as infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; patient education systems; and office forms and stationery.
Recommended Story: Quiet Period Expirations
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.